Back

Empagliflozin directly improves diastolic function in human heart failure

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters 2 - Best Posters in cardiac remodelling and dysfunction Heart Failure ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Steffen Pabel

Massachusetts General Hospital, Boston (Germany)

3 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor F. Hohendanner (Berlin, DE)
Abstract
Presentation thumbnail
Doctor K. Nishimura (Nagoya, JP)
Abstract

Access the full session

Session thumbnail
Best Posters 2 - Best Posters in cardiac remodelling and dysfunction

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Treatment with empagliflozin improves cardiac function in infarcted animals associated with increased baroreflex sensitivity
27 August 2023
thumbnail
Congress Presentation
Effects of dapagliflozin on left ventricular global longitudinal strain correlated with basal functional capacity
22 May 2023
thumbnail
Congress Session
Late-breaking science in acute heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources